OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
The Trouble with CBD Oil
Arno Hazekamp
Medical Cannabis and Cannabinoids (2018) Vol. 1, Iss. 1, pp. 65-72
Open Access | Times Cited: 158
Arno Hazekamp
Medical Cannabis and Cannabinoids (2018) Vol. 1, Iss. 1, pp. 65-72
Open Access | Times Cited: 158
Showing 1-25 of 158 citing articles:
The antimicrobial potential of cannabidiol
Mark A. T. Blaskovich, Angela M. Kavanagh, Alysha G. Elliott, et al.
Communications Biology (2021) Vol. 4, Iss. 1
Open Access | Times Cited: 222
Mark A. T. Blaskovich, Angela M. Kavanagh, Alysha G. Elliott, et al.
Communications Biology (2021) Vol. 4, Iss. 1
Open Access | Times Cited: 222
A Review of Human Studies Assessing Cannabidiol's (CBD) Therapeutic Actions and Potential
C Michael White
The Journal of Clinical Pharmacology (2019) Vol. 59, Iss. 7, pp. 923-934
Closed Access | Times Cited: 212
C Michael White
The Journal of Clinical Pharmacology (2019) Vol. 59, Iss. 7, pp. 923-934
Closed Access | Times Cited: 212
Medicinal use of cannabis based products and cannabinoids
Tom P. Freeman, Chandni Hindocha, Sebastian F Green, et al.
BMJ (2019), pp. l1141-l1141
Open Access | Times Cited: 202
Tom P. Freeman, Chandni Hindocha, Sebastian F Green, et al.
BMJ (2019), pp. l1141-l1141
Open Access | Times Cited: 202
A systematic review of cannabidiol dosing in clinical populations
Sophie Millar, Nicole L. Stone, Z.D. Bellman, et al.
British Journal of Clinical Pharmacology (2019) Vol. 85, Iss. 9, pp. 1888-1900
Open Access | Times Cited: 197
Sophie Millar, Nicole L. Stone, Z.D. Bellman, et al.
British Journal of Clinical Pharmacology (2019) Vol. 85, Iss. 9, pp. 1888-1900
Open Access | Times Cited: 197
Therapeutic Potential of Cannabis, Cannabidiol, and Cannabinoid-Based Pharmaceuticals
Christopher A. Legare, Wesley M. Raup‐Konsavage, Kent E. Vrana
Pharmacology (2022) Vol. 107, Iss. 3-4, pp. 131-149
Open Access | Times Cited: 172
Christopher A. Legare, Wesley M. Raup‐Konsavage, Kent E. Vrana
Pharmacology (2022) Vol. 107, Iss. 3-4, pp. 131-149
Open Access | Times Cited: 172
The current use and evolving landscape of nutraceuticals
Avijeet Chopra, Ronan Lordan, Olaf K. Horbańczuk, et al.
Pharmacological Research (2021) Vol. 175, pp. 106001-106001
Open Access | Times Cited: 146
Avijeet Chopra, Ronan Lordan, Olaf K. Horbańczuk, et al.
Pharmacological Research (2021) Vol. 175, pp. 106001-106001
Open Access | Times Cited: 146
Cannabidiol—from Plant to Human Body: A Promising Bioactive Molecule with Multi-Target Effects in Cancer
Brigitta Kis, Feng Chen Ifrim, Valentina Buda, et al.
International Journal of Molecular Sciences (2019) Vol. 20, Iss. 23, pp. 5905-5905
Open Access | Times Cited: 116
Brigitta Kis, Feng Chen Ifrim, Valentina Buda, et al.
International Journal of Molecular Sciences (2019) Vol. 20, Iss. 23, pp. 5905-5905
Open Access | Times Cited: 116
Conversion of Cannabidiol (CBD) into Psychotropic Cannabinoids Including Tetrahydrocannabinol (THC): A Controversy in the Scientific Literature
Patricia Golombek, Marco Müller, Ines Barthlott, et al.
Toxics (2020) Vol. 8, Iss. 2, pp. 41-41
Open Access | Times Cited: 115
Patricia Golombek, Marco Müller, Ines Barthlott, et al.
Toxics (2020) Vol. 8, Iss. 2, pp. 41-41
Open Access | Times Cited: 115
Palmitoylethanolamide: A Natural Compound for Health Management
Paul Clayton, Mariko Hill, Nathasha Bogoda, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 10, pp. 5305-5305
Open Access | Times Cited: 87
Paul Clayton, Mariko Hill, Nathasha Bogoda, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 10, pp. 5305-5305
Open Access | Times Cited: 87
Cannabis use in Europe: Current trends and public health concerns
Jakob Manthey
International Journal of Drug Policy (2019) Vol. 68, pp. 93-96
Closed Access | Times Cited: 81
Jakob Manthey
International Journal of Drug Policy (2019) Vol. 68, pp. 93-96
Closed Access | Times Cited: 81
Access to cannabidiol without a prescription: A cross-country comparison and analysis
Iain S. McGregor, Elizabeth A. Cairns, Sarah V. Abelev, et al.
International Journal of Drug Policy (2020) Vol. 85, pp. 102935-102935
Open Access | Times Cited: 80
Iain S. McGregor, Elizabeth A. Cairns, Sarah V. Abelev, et al.
International Journal of Drug Policy (2020) Vol. 85, pp. 102935-102935
Open Access | Times Cited: 80
Risks and Benefits of Cannabis and Cannabinoids in Psychiatry
Kevin P. Hill, Mark S. Gold, Charles B. Nemeroff, et al.
American Journal of Psychiatry (2021) Vol. 179, Iss. 2, pp. 98-109
Closed Access | Times Cited: 67
Kevin P. Hill, Mark S. Gold, Charles B. Nemeroff, et al.
American Journal of Psychiatry (2021) Vol. 179, Iss. 2, pp. 98-109
Closed Access | Times Cited: 67
Cannabis-Based Products for the Treatment of Skin Inflammatory Diseases: A Timely Review
A.M. Martins, Ana Luísa Gomes, Inês Vilas Boas, et al.
Pharmaceuticals (2022) Vol. 15, Iss. 2, pp. 210-210
Open Access | Times Cited: 53
A.M. Martins, Ana Luísa Gomes, Inês Vilas Boas, et al.
Pharmaceuticals (2022) Vol. 15, Iss. 2, pp. 210-210
Open Access | Times Cited: 53
Cannabis and cannabinoids for symptomatic treatment for people with multiple sclerosis
Graziella Filippini, Silvia Minozzi, Francesca Borrelli, et al.
Cochrane library (2022)
Open Access | Times Cited: 50
Graziella Filippini, Silvia Minozzi, Francesca Borrelli, et al.
Cochrane library (2022)
Open Access | Times Cited: 50
Evaluation of dispensaries’ cannabis flowers for accuracy of labeling of cannabinoids content
Mona M. Geweda, Chandrani G. Majumdar, Malorie N Moore, et al.
Journal of Cannabis Research (2024) Vol. 6, Iss. 1
Open Access | Times Cited: 10
Mona M. Geweda, Chandrani G. Majumdar, Malorie N Moore, et al.
Journal of Cannabis Research (2024) Vol. 6, Iss. 1
Open Access | Times Cited: 10
Product labeling accuracy and contamination analysis of commercially available cannabidiol product samples
Barry E. Gidal, Ryan G. Vandrey, Chela Wallin, et al.
Frontiers in Pharmacology (2024) Vol. 15
Open Access | Times Cited: 10
Barry E. Gidal, Ryan G. Vandrey, Chela Wallin, et al.
Frontiers in Pharmacology (2024) Vol. 15
Open Access | Times Cited: 10
Validated LC-MS/MS methodology for the quantification of CBD, trace level THCA and UK controlled cannabinoids (Δ9THC, Δ8THC, CBN and THCV) in food samples
Tabatha Hambidge, Ralph G. Nash, Steve Corless, et al.
Analytical Methods (2025)
Open Access | Times Cited: 1
Tabatha Hambidge, Ralph G. Nash, Steve Corless, et al.
Analytical Methods (2025)
Open Access | Times Cited: 1
An Analysis of Over-the-Counter Cannabidiol Products in the United Kingdom
Jonathan Paul Liebling, Nicholas James Clarkson, Blair William Gibbs, et al.
Cannabis and Cannabinoid Research (2020) Vol. 7, Iss. 2, pp. 207-213
Open Access | Times Cited: 58
Jonathan Paul Liebling, Nicholas James Clarkson, Blair William Gibbs, et al.
Cannabis and Cannabinoid Research (2020) Vol. 7, Iss. 2, pp. 207-213
Open Access | Times Cited: 58
The relationship between cannabis/hemp use in foods and processing methodology
Jerry W. King
Current Opinion in Food Science (2019) Vol. 28, pp. 32-40
Closed Access | Times Cited: 57
Jerry W. King
Current Opinion in Food Science (2019) Vol. 28, pp. 32-40
Closed Access | Times Cited: 57
Cannabis Contaminants Limit Pharmacological Use of Cannabidiol
Zackary T. Montoya, Matthieu Conroy, Brian D. Vanden Heuvel, et al.
Frontiers in Pharmacology (2020) Vol. 11
Open Access | Times Cited: 54
Zackary T. Montoya, Matthieu Conroy, Brian D. Vanden Heuvel, et al.
Frontiers in Pharmacology (2020) Vol. 11
Open Access | Times Cited: 54
Exploring the use of cannabis as a substitute for prescription drugs in a convenience sample
Sinikka L. Kvamme, Michael Mulbjerg Pedersen, Kristine Rømer Thomsen, et al.
Harm Reduction Journal (2021) Vol. 18, Iss. 1
Open Access | Times Cited: 41
Sinikka L. Kvamme, Michael Mulbjerg Pedersen, Kristine Rømer Thomsen, et al.
Harm Reduction Journal (2021) Vol. 18, Iss. 1
Open Access | Times Cited: 41
Cannabidiol (CBD) product contamination: Quantitative analysis of Δ9-tetrahydrocannabinol (Δ9-THC) concentrations found in commercially available CBD products
Erin M. Johnson, Michael Kilgore, Shanna Babalonis
Drug and Alcohol Dependence (2022) Vol. 237, pp. 109522-109522
Open Access | Times Cited: 35
Erin M. Johnson, Michael Kilgore, Shanna Babalonis
Drug and Alcohol Dependence (2022) Vol. 237, pp. 109522-109522
Open Access | Times Cited: 35
Label accuracy of unregulated cannabidiol (CBD) products: measured concentration vs. label claim
Erin M. Johnson, Michael Kilgore, Shanna Babalonis
Journal of Cannabis Research (2022) Vol. 4, Iss. 1
Open Access | Times Cited: 35
Erin M. Johnson, Michael Kilgore, Shanna Babalonis
Journal of Cannabis Research (2022) Vol. 4, Iss. 1
Open Access | Times Cited: 35
Cannabis sativa Cannabinoids as Functional Ingredients in Snack Foods—Historical and Developmental Aspects
Marlize Krüger, Tertia van Eeden, Daniso Beswa
Plants (2022) Vol. 11, Iss. 23, pp. 3330-3330
Open Access | Times Cited: 34
Marlize Krüger, Tertia van Eeden, Daniso Beswa
Plants (2022) Vol. 11, Iss. 23, pp. 3330-3330
Open Access | Times Cited: 34
Skin applications of cannabidiol: sources, effects, delivery systems, marketed formulations and safety
Beatriz Pires Ferreira, Gustavo Costa, Filipa Mascarenhas‐Melo, et al.
Phytochemistry Reviews (2023) Vol. 22, Iss. 3, pp. 781-828
Open Access | Times Cited: 16
Beatriz Pires Ferreira, Gustavo Costa, Filipa Mascarenhas‐Melo, et al.
Phytochemistry Reviews (2023) Vol. 22, Iss. 3, pp. 781-828
Open Access | Times Cited: 16
